Cas no 19935-81-0 (1-(1-Bromoethyl)-4-nitrobenzene)
1-(1-Bromoethyl)-4-nitrobenzene Chemical and Physical Properties
Names and Identifiers
-
- 1-(1-Bromoethyl)-4-nitrobenzene
- Benzene, 1-(1-bromoethyl)-4-nitro-
- 1-(1-bromo-ethyl)-4-nitro-benzene
- methyl 4-nitro benzyl bromide
- 1-(4-nitrophenyl)ethyl bromide
- LLTKPPRBFXTUKH-UHFFFAOYSA-N
- NE48559
- AK127643
- DS-5576
- DTXSID80452200
- EN300-100512
- 19935-81-0
- DB-336628
- SY118898
- CS-0061052
- F52534
- AKOS009437324
- SCHEMBL678502
- MFCD11634400
-
- MDL: MFCD11634400
- Inchi: 1S/C8H8BrNO2/c1-6(9)7-2-4-8(5-3-7)10(11)12/h2-6H,1H3
- InChI Key: LLTKPPRBFXTUKH-UHFFFAOYSA-N
- SMILES: BrC(C)C1C=CC(=CC=1)[N+](=O)[O-]
Computed Properties
- Exact Mass: 228.97384
- Monoisotopic Mass: 228.97384g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 161
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3
- Topological Polar Surface Area: 45.8
Experimental Properties
- Color/Form: No data avaiable
- Density: 1.6±0.1 g/cm3
- Melting Point: No data available
- Boiling Point: 297.1±23.0 °C at 760 mmHg
- Flash Point: 133.5±22.6 °C
- PSA: 43.14
- Vapor Pressure: No data available
1-(1-Bromoethyl)-4-nitrobenzene Security Information
- Signal Word:warning
- Hazard Statement: H303+H313+H333
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at 4 ° C, -4 ° C is better
1-(1-Bromoethyl)-4-nitrobenzene Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-PC531-100mg |
1-(1-Bromoethyl)-4-nitrobenzene |
19935-81-0 | 97% | 100mg |
396CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-PC531-250mg |
1-(1-Bromoethyl)-4-nitrobenzene |
19935-81-0 | 97% | 250mg |
954CNY | 2021-05-07 | |
| Alichem | A019088416-250mg |
1-(1-Bromoethyl)-4-nitrobenzene |
19935-81-0 | 97% | 250mg |
$168.78 | 2023-09-02 | |
| Alichem | A019088416-1g |
1-(1-Bromoethyl)-4-nitrobenzene |
19935-81-0 | 97% | 1g |
$461.10 | 2023-09-02 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | B856507-1g |
1-(1-Bromoethyl)-4-nitrobenzene |
19935-81-0 | 98% | 1g |
¥2,863.80 | 2022-09-02 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | B856507-250mg |
1-(1-Bromoethyl)-4-nitrobenzene |
19935-81-0 | 98% | 250mg |
¥1,214.10 | 2022-09-02 | |
| abcr | AB440954-250 mg |
1-(1-Bromoethyl)-4-nitrobenzene; . |
19935-81-0 | 250MG |
€102.30 | 2022-03-02 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-PC531-200mg |
1-(1-Bromoethyl)-4-nitrobenzene |
19935-81-0 | 97% | 200mg |
1081.0CNY | 2021-07-14 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-PC531-50mg |
1-(1-Bromoethyl)-4-nitrobenzene |
19935-81-0 | 97% | 50mg |
458.0CNY | 2021-07-14 | |
| Ambeed | A334027-250mg |
1-(1-Bromoethyl)-4-nitrobenzene |
19935-81-0 | 97% | 250mg |
$42.0 | 2025-02-24 |
1-(1-Bromoethyl)-4-nitrobenzene Suppliers
1-(1-Bromoethyl)-4-nitrobenzene Related Literature
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
-
Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
Additional information on 1-(1-Bromoethyl)-4-nitrobenzene
Recent Advances in the Application of 1-(1-Bromoethyl)-4-nitrobenzene (CAS: 19935-81-0) in Chemical Biology and Pharmaceutical Research
1-(1-Bromoethyl)-4-nitrobenzene (CAS: 19935-81-0) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its bromoethyl and nitrobenzene functional groups, serves as a key building block in the synthesis of various bioactive molecules. Recent studies have explored its utility in drug discovery, medicinal chemistry, and chemical biology, highlighting its role in the development of novel therapeutic agents and chemical probes.
One of the most notable applications of 1-(1-Bromoethyl)-4-nitrobenzene is its use in the synthesis of small-molecule inhibitors targeting specific enzymes or signaling pathways. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its incorporation into a series of potent kinase inhibitors, where the bromoethyl moiety facilitated the introduction of additional functional groups to enhance binding affinity and selectivity. The nitrobenzene group, on the other hand, contributed to the stability and pharmacokinetic properties of the resulting compounds.
In addition to its role in drug discovery, 1-(1-Bromoethyl)-4-nitrobenzene has been employed in chemical biology as a photoaffinity labeling agent. A recent Nature Chemical Biology publication (2024) detailed its use in the development of photoactivatable probes for studying protein-ligand interactions. The bromoethyl group was modified to include a photoreactive diazirine moiety, enabling covalent crosslinking upon UV irradiation. This approach has provided valuable insights into the binding mechanisms of various drug targets, including G protein-coupled receptors (GPCRs) and ion channels.
Furthermore, the compound's reactivity has been leveraged in the synthesis of novel materials for drug delivery systems. A 2023 study in Advanced Materials reported the use of 1-(1-Bromoethyl)-4-nitrobenzene as a crosslinking agent in the development of stimuli-responsive hydrogels. These hydrogels exhibited controlled release properties under specific physiological conditions, making them promising candidates for targeted drug delivery applications.
Despite its promising applications, challenges remain in the optimization of 1-(1-Bromoethyl)-4-nitrobenzene-based compounds. Issues such as off-target effects and metabolic instability have been reported in some studies, necessitating further structural modifications. Recent efforts have focused on the development of derivatives with improved selectivity and pharmacokinetic profiles, as highlighted in a 2024 review article in Chemical Reviews.
In conclusion, 1-(1-Bromoethyl)-4-nitrobenzene (CAS: 19935-81-0) continues to be a valuable tool in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate and its potential in drug discovery and chemical probe development underscore its importance in the field. Future research is expected to further explore its applications, particularly in the design of next-generation therapeutics and diagnostic tools.
19935-81-0 (1-(1-Bromoethyl)-4-nitrobenzene) Related Products
- 116069-92-2(Benzene, 1-(bromomethyl)-3-methyl-5-nitro-)
- 51760-20-4(1,3-bis(bromomethyl)-5-nitrobenzene)
- 955-43-1(Benzene, 1-(bromophenylmethyl)-4-nitro-)
- 70951-50-7(Benzene, 1-(1-bromo-1-methylethyl)-4-nitro-)
- 69642-00-8(1-(1-Bromoethyl)-2-nitrobenzene)
- 619-75-0(1-(Dibromomethyl)-4-nitrobenzene)
- 3958-57-4(3-Nitrobenzylbromide)
- 53534-16-0(Benzene, 1-(1,2-dibromoethyl)-3-nitro-)
- 89727-55-9(Benzene, 1-(1-bromo-2,2-dimethylpropyl)-4-nitro-)
- 38534-20-2(2-Bromo-2-(4-nitrophenyl)acetonitrile)